ATE512200T1 - Hydrogele mit wasserstoffbrückenbindungen - Google Patents

Hydrogele mit wasserstoffbrückenbindungen

Info

Publication number
ATE512200T1
ATE512200T1 AT06733083T AT06733083T ATE512200T1 AT E512200 T1 ATE512200 T1 AT E512200T1 AT 06733083 T AT06733083 T AT 06733083T AT 06733083 T AT06733083 T AT 06733083T AT E512200 T1 ATE512200 T1 AT E512200T1
Authority
AT
Austria
Prior art keywords
hydrogeles
hydrogen bonds
new
hydrogel
tuned
Prior art date
Application number
AT06733083T
Other languages
English (en)
Inventor
Gemert Gaby Maria Hoorne-Van
Anton Bosman
Egbert Meijer
Henricus Janssen
Original Assignee
Suprapolix Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suprapolix Bv filed Critical Suprapolix Bv
Application granted granted Critical
Publication of ATE512200T1 publication Critical patent/ATE512200T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/12—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity
    • C08L101/14—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity the macromolecular compounds being water soluble or water swellable, e.g. aqueous gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Colloid Chemistry (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT06733083T 2005-05-04 2006-05-03 Hydrogele mit wasserstoffbrückenbindungen ATE512200T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05103763 2005-05-04
US67964905P 2005-05-11 2005-05-11
PCT/NL2006/050106 WO2006118460A1 (en) 2005-05-04 2006-05-03 Hydrogen bonded hydrogels

Publications (1)

Publication Number Publication Date
ATE512200T1 true ATE512200T1 (de) 2011-06-15

Family

ID=35708383

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06733083T ATE512200T1 (de) 2005-05-04 2006-05-03 Hydrogele mit wasserstoffbrückenbindungen

Country Status (6)

Country Link
US (1) US8246990B2 (de)
EP (1) EP1907482B1 (de)
JP (2) JP2008540725A (de)
AT (1) ATE512200T1 (de)
ES (1) ES2367583T3 (de)
WO (1) WO2006118460A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7838621B2 (en) 2003-11-04 2010-11-23 Suprapolix B.V. Preparation of supramolecular polymer containing quadruple hydrogen bonding units in the polymer backbone
US8268952B2 (en) 2004-07-12 2012-09-18 Suprapolix B.V. Supramolecular ionomers
ATE532540T1 (de) 2005-05-04 2011-11-15 Suprapolix Bv Modulare bioresorbierbare oder biomedizinische biologisch aktive supramolekulare stoffe
EP1907482B1 (de) 2005-05-04 2011-06-08 SupraPolix B.V. Hydrogele mit wasserstoffbrückenbindungen
ES2575933T3 (es) 2006-05-31 2016-07-04 Baxter International Inc. Colágeno para su uso en la prevención de la formación de fibrosis epidural después de cirugía espinal
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
EP2087027B1 (de) 2006-11-20 2011-10-05 SupraPolix B.V. Supramolekulare polymere aus niedrigschmelzenden, leicht verarbeitbaren bausteinen
US8628789B2 (en) 2007-03-23 2014-01-14 Suprapolix, B.V. Strong reversible hydrogels
ATE515538T1 (de) * 2007-03-23 2011-07-15 Suprapolix Bv Starke umkehrbare hydrogels
JP2011500237A (ja) 2007-10-30 2011-01-06 バクスター・インターナショナル・インコーポレイテッド 内臓または体腔壁の欠陥を治療するための再生性の生体機能性コラーゲン生物基質の使用
WO2010002262A1 (en) * 2008-07-04 2010-01-07 Suprapolix B.V. High flow supramolecular compounds
FR2933295B1 (fr) * 2008-07-04 2010-07-30 Oreal Composition cosmetique ou dermatologique comprenant un compose capable d'etablir des liaisons hydrogene, et procede de traitement cosmetique
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
ES2532428T3 (es) 2009-06-16 2015-03-26 Baxter International Inc Esponja hemostática
AU2010339045B2 (en) 2009-12-16 2014-06-05 Baxter Healthcare S.A. Hemostatic sponge
FR2954132B1 (fr) * 2009-12-18 2015-03-13 Oreal Composition cosmetique comprenant un compose supramoleculaire capable d'etablir des liaisons hydrogene et un corps gras pateux apolaire
FR2954130B1 (fr) * 2009-12-18 2012-02-24 Oreal Composition cosmetique comprenant un compose supramoleculaire capable d'etablir des liaisons hydrogene, et un ingredient additionnel particulier
FR2954131B1 (fr) * 2009-12-18 2016-02-19 Oreal Composition cosmetique comprenant un compose supramoleculaire capable d'etablir des liaisons hydrogene, et une huile particuliere
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
CA2801120C (en) 2010-06-01 2019-08-20 Baxter International Inc. Process for making dry and stable hemostatic compositions
EP2575770B1 (de) 2010-06-01 2017-03-22 Baxter International Inc Verfahren zur herstellung von trockenen und stabilen hämostatischen zusammensetzungen
KR101814841B1 (ko) 2010-06-01 2018-01-03 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
EP2450394B1 (de) 2010-11-05 2017-06-07 SupraPolix B.V. Verfahren zur Herstellung eines supramolekularen Polymers
JP6228012B2 (ja) 2011-01-19 2017-11-08 プレジデント アンド フェローズ オブ ハーバード カレッジ 高圧力安定性、光透過性、および自己修復特性を伴う易滑性表面
US9932484B2 (en) 2011-01-19 2018-04-03 President And Fellows Of Harvard College Slippery liquid-infused porous surfaces and biological applications thereof
WO2012168392A1 (en) * 2011-06-07 2012-12-13 Technische Universiteit Eindhoven Hydrogelator with shape-memory properties
JP6195569B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
AU2012318258B2 (en) 2011-10-11 2015-07-09 Baxter Healthcare S.A. Hemostatic compositions
UY34414A (es) 2011-10-27 2013-04-30 Baxter Int Composiciones hemostáticas
AU2013289879B2 (en) * 2012-07-12 2017-04-06 President And Fellows Of Harvard College Slippery self-lubricating polymer surfaces
EP2872574A1 (de) 2012-07-13 2015-05-20 President and Fellows of Harvard College Gleitende oberfläche auf der basis einer metallhaltigen verbindung
WO2014012039A1 (en) 2012-07-13 2014-01-16 President And Fellows Of Harvard College Slippery liquid-infused porous surfaces having improved stability
US10385181B2 (en) 2013-03-13 2019-08-20 President And Fellows Of Harvard College Solidifiable composition for preparaton of liquid-infused slippery surfaces and methods of applying
WO2016018145A1 (en) 2014-07-28 2016-02-04 Suprapolix B.V. Durable hydrogen bonded hydrogels
JP6496967B2 (ja) * 2014-11-25 2019-04-10 花王株式会社 化粧料用重合体
JP6757329B2 (ja) * 2015-04-02 2020-09-16 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 自己組み込み型ヒドロゲル及びその製造方法
US11911532B2 (en) 2017-03-29 2024-02-27 The Regents Of The University Of Colorado, A Body Corporate Reverse thermal gels and their use as vascular embolic repair agents
EP3706800A4 (de) * 2017-11-10 2021-08-25 University of Massachusetts Abgabesysteme auf der basis von hydrogelzusammensetzungen und verfahren dafür
NL2019957B1 (en) * 2017-11-22 2019-05-29 Suprapolix Bv Supramolecular biomedical polymers
WO2020077160A1 (en) 2018-10-11 2020-04-16 Freeflow Medical Devices Llc Fluoropolymer based anti-thrombotic coatings
WO2020077161A1 (en) 2018-10-11 2020-04-16 Freeflow Medical Devices Llc Packaging for medical devices coated with perfluorinated liquids or dispersions thereof
WO2020232111A1 (en) * 2019-05-15 2020-11-19 President And Fellows Of Harvard College Instant and tough adhesion
CN110183690B (zh) * 2019-06-06 2021-11-12 上海工程技术大学 一种聚乙烯醇/改性纳米纤维素超分子水凝胶及其制备方法和应用
CN110922612B (zh) * 2019-12-02 2022-10-28 哈尔滨工程大学 一种离子型导电抗冻超分子水凝胶的制备方法
NL2027371B1 (en) 2021-01-22 2022-08-05 Acad Medisch Ct Injectable cushioning hydrogels
GB202205568D0 (en) 2022-04-14 2022-06-01 Reckitt Benckiser Health Ltd Condom
NL2034152B1 (en) 2023-02-15 2024-09-03 Suprapolix Bv Ph-switchable hydrogel

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092918B1 (de) 1982-04-22 1988-10-19 Imperial Chemical Industries Plc Mittel mit verzögerter Freigabe
KR0148704B1 (ko) 1994-01-10 1998-08-17 김상응 생체분해성 약물전달용 고분자
US5883211A (en) * 1996-01-19 1999-03-16 Aclara Biosciences, Inc. Thermoreversible hydrogels comprising linear copolymers and their use in electrophoresis
JPH09235213A (ja) * 1996-02-29 1997-09-09 Kanebo Ltd ゲル状整髪料
NL1004192C2 (nl) * 1996-10-04 1998-04-07 Dsm Nv Supramoleculair polymeer.
EP1024790A4 (de) 1997-08-08 2000-10-25 Univ Utah Res Found Injizierbare biologisch abbaubare blockcopolymergele zur verwendung in der arzneistoffverabreichung
IL135148A0 (en) 1997-10-03 2001-05-20 Galenica Pharmaceuticals Inc A polysaccharide conjugate and pharmaceutical compositions containing the same
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
EP1213309A1 (de) * 2000-12-05 2002-06-12 Huntsman International Llc Polymer, das ein supramolekulares Polymer formt
JP2002167308A (ja) * 2000-12-01 2002-06-11 Kanebo Ltd ゲル状整髪料
FR2825628B1 (fr) * 2001-06-07 2004-03-19 Oreal Composition cosmetique comportant un polymere comprenant des groupes de jonction capables d'etablir chacun au moins trois liaisons h
US6972304B2 (en) 2001-09-07 2005-12-06 Xerox Corporation Aqueous ink compositions
GB0124967D0 (en) 2001-10-17 2001-12-05 Unilever Plc Cosmetic and personal care compositions
EP1511794B1 (de) 2002-05-27 2007-05-02 Huntsman International Llc Expandierte supramolekulare polymere
US6803447B2 (en) * 2002-08-16 2004-10-12 Eutechpark Mmp1.28 Preparation of supramolecular polymers by copolymerization of monomers containing quadruple hydrogen bonding units with regular monomers
US7838621B2 (en) * 2003-11-04 2010-11-23 Suprapolix B.V. Preparation of supramolecular polymer containing quadruple hydrogen bonding units in the polymer backbone
EP1907482B1 (de) 2005-05-04 2011-06-08 SupraPolix B.V. Hydrogele mit wasserstoffbrückenbindungen

Also Published As

Publication number Publication date
JP5607127B2 (ja) 2014-10-15
US20090004274A1 (en) 2009-01-01
ES2367583T3 (es) 2011-11-10
ES2367583T5 (es) 2011-11-04
EP1907482B1 (de) 2011-06-08
US8246990B2 (en) 2012-08-21
JP2008540725A (ja) 2008-11-20
JP2013047346A (ja) 2013-03-07
EP1907482A1 (de) 2008-04-09
WO2006118460A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
ATE512200T1 (de) Hydrogele mit wasserstoffbrückenbindungen
CY2019002I1 (el) Εγκαρσια συνδεδεμενα πολυμερη ανταλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας
EP4406557A3 (de) Materialien und verfahren zur verbesserung der magen-darm-funktion
WO2008039655A3 (en) Pendant end-capped low modulus cationic siloxanyls
WO2007061874A3 (en) Methods and compositions for use in treating cancer
WO2003061593A3 (en) Novel targeted compositions for diagnostic and therapeutic use
AU306305S (en) Toothbrush
BRPI0519046A2 (pt) composição de xampu
AU303137S (en) Bottle
AU303136S (en) Bottle
ATE437896T1 (de) Flüssige dispersionspolymerzusammensetzungen, ihre herstellung und ihre verwendung
ATE515538T1 (de) Starke umkehrbare hydrogels
WO2007096708A3 (en) Macro-diacrylates and macro-polyacrylates
MX2012012776A (es) Composicion de quitosano.
WO2011160641A3 (en) Hydrophilic gels from polyurethane-based photoinitiators
CA2726043A1 (en) Oral care composition comprising an adhesive component
AU307436S (en) Angle grinder
TW200641025A (en) Reverse phase hydrophilic polymers and their use in water-expandandable elastomeric compositions
ATE483720T1 (de) Verbindungen enthaltend organofluorochlorophosphatanionen
BR112012031311A2 (pt) "material polimérico conjugado e seus usos"
ATE363890T1 (de) Kationische polymerisate und deren verwendung in kosmetischen formulierungen
AU306157S (en) Toothbrush
WO2007072018A3 (en) Redox mediators
ATE533517T1 (de) Biologisch abbaubare polyphosphazene mit pyrrolidonseitengruppen
GB0818080D0 (en) Immunogenic peptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties